Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Crossref DOI link: https://doi.org/10.1186/s12885-016-2279-0
Published Online: 2016-03-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chang, Yen-Hou
Li, Wai-Hou
Chang, Yi
Peng, Chia-Wen
Cheng, Ching-Hsuan
Chang, Wei-Pin
Chuang, Chi-Mu
License valid from 2016-03-17